BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24483195)

  • 1. New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.
    Coppola S; Caracciolo G
    Ther Deliv; 2014 Feb; 5(2):173-88. PubMed ID: 24483195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
    Mohamed S; Parayath NN; Taurin S; Greish K
    Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic colocalization microscopy to characterize intracellular trafficking of nanomedicines.
    Vercauteren D; Deschout H; Remaut K; Engbersen JF; Jones AT; Demeester J; De Smedt SC; Braeckmans K
    ACS Nano; 2011 Oct; 5(10):7874-84. PubMed ID: 21923168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosylated block copolymers: a versatile nano-based tool for effective intracellular drug delivery?
    Canton I; Ustbas B; Armes SP
    Ther Deliv; 2014 Feb; 5(2):105-7. PubMed ID: 24483188
    [No Abstract]   [Full Text] [Related]  

  • 5. Layer-by-layer assembly of multilayer films for controlled drug release.
    Choi D; Hong J
    Arch Pharm Res; 2014 Jan; 37(1):79-87. PubMed ID: 24277693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification and local orientations of surface molecules in nanotherapeutics.
    Amin ML; Joo JY; Yi DK; An SS
    J Control Release; 2015 Jun; 207():131-42. PubMed ID: 25883030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalative nanomedicine--opportunities and challenges.
    Bur M; Henning A; Hein S; Schneider M; Lehr CM
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():137-43. PubMed ID: 19558246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods.
    Vercauteren D; Rejman J; Martens TF; Demeester J; De Smedt SC; Braeckmans K
    J Control Release; 2012 Jul; 161(2):566-81. PubMed ID: 22613879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain.
    Leyva-Gómez G; Cortés H; Magaña JJ; Leyva-García N; Quintanar-Guerrero D; Florán B
    Drug Discov Today; 2015 Jul; 20(7):824-37. PubMed ID: 25701281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
    Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
    J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into cellular uptake of nanoparticles.
    Kafshgari MH; Harding FJ; Voelcker NH
    Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-based oral peptide nanomedicines.
    Herrero EP; Alonso MJ; Csaba N
    Ther Deliv; 2012 May; 3(5):657-68. PubMed ID: 22834409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicines for delivery of therapeutic proteins and biopharmaceuticals.
    Sarmento B
    Ther Deliv; 2010 Aug; 1(2):231-5. PubMed ID: 22816130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
    Babu A; Templeton AK; Munshi A; Ramesh R
    AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable chimaeric polymersomes mediate highly efficient delivery of exogenous proteins into cells.
    Cheng R; Liu G; Ma S; Li S; Meng F; Liu H; Zhong Z
    J Control Release; 2011 Nov; 152 Suppl 1():e136-7. PubMed ID: 22195804
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecularly imprinted polymers as the future drug delivery devices.
    Luliński P
    Acta Pol Pharm; 2013; 70(4):601-9. PubMed ID: 23923384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.